Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
47.90
-0.40 (-0.83%)
At close: Apr 10, 2026, 4:00 PM EDT
47.72
-0.18 (-0.38%)
After-hours: Apr 10, 2026, 4:59 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $27.63 billion as of April 10, 2026. Its market cap has increased by 88.88% in one year.
Market Cap
27.63B
Enterprise Value
35.95B
1-Year Change
88.88%
Ranking
Category
Stock Price
$47.90
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $27.63B, an increase of 75.32%. That is a compound annual growth rate of 10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 20.69B | 25.34% |
| Dec 31, 2025 | 16.51B | 45.66% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 49.22B |
| Alnylam Pharmaceuticals | 43.11B |
| BeOne Medicines AG | 34.44B |
| Insmed | 33.62B |
| BioNTech SE | 23.69B |
| Moderna | 20.65B |
| Roivant Sciences | 20.06B |
| Incyte | 19.14B |